TTL-315

N/A

Report date: 2025/01/26 16:55:04
NME

Base Information

Drug NameTTL-315
Drug Alias NameTTL-315
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTelesis Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesTelesis Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A